This book chapter advances SDG #3 and #10 by reviewing neural regeneration–based therapeutic approaches as it represents a highly promising therapeutic strategy for AD, including research that CNTF small-molecule peptide mimetic has demonstrated that neural regeneration–based strategy can also be disease modifying for AD.

This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by discussing insights into the regulation and induction of bnAbs based on the use of KI models.

The last few years have seen a phenomenal upsurge in the number of corporate bankruptcies.

Rationale Much of the data on the acceptability of HIV Pre-Exposure Prophylaxis (PrEP) is based on willingness to take PrEP (i.e., hypothetical receptivity) rather than actual intentions (i.e., pla

Lesbian, gay, bisexual, transgender (LGBT), and questioning youth represent a diverse population who are affected by many sexual health inequities, including increased risk for human immunodeficien

Automated vehicles represent a technology that promises to increase mobility for many groups, including the senior population (those over age 65) but also for non-drivers and people with medical co

Focuses on homelessness from a public health perspective – its prevalence, its relationship to specific health conditions, and various interventions intended to ameliorate homelessness and the health problems with which it is associated.

Cognitive Behaviour Therapy has been demonstrated to be an effective intervention in outpatient and inpatient settings for a wide range of presenting mental health problems including depression, Ob

Young gay and bisexual men are at increased risk for human immunodeficiency virus (HIV) infection.

This book chapter advances SDG #3 and #10 by providing a brief outline of AD epidemiology, the definition of an AD biomarker, the classification and features of AD, and AD risk factors, followed by a description of the structure and content of each of the following chapters and their focus on specific types of AD biomarkers.